AN2 Therapeutics, Inc.(简称AN2 Therapeutics)近日正式发布了其2025年第四季度及全年的财务报告,同时概述了公司在业务拓展与科学研究方面取得的最新成果。
AN2 Therapeutics, Inc.(简称AN2 Therapeutics)近日正式发布了其2025年第四季度及全年的财务报告,同时概述了公司在业务拓展与科学研究方面取得的最新成果。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.